CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...